Nissin Foods and Toyota Partner to Realize Well-Being for All Through Food
Nissin Food Products Co., Ltd. (Nissin Foods) and Toyota Motor Corporation (Toyota) have initiated an agreement to jointly foster human well-being through healthy eating. This proposed plan will explore using Nissin’s innovative food offering, based on the latest molecular nutritional science, to provide personalized, delicious, and healthy “Complete Nutrition Meals” for Woven City. Woven City is being developed in Susono City, Shizuoka Prefecture on behalf of Toyota by Woven Planet, Inc. (Woven Planet), a Toyota subsidiary.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220425005380/en/
(Graphic: Business Wire)
Specifically, the following initiatives will be considered.
(1) A joint demonstration on expanding food choices for Woven City and improve residents’ health through the provision of "Complete Nutrition Meals”
(2) Connect data to provide "Complete Nutrition Meals" optimization based on each individual’s needs
Through Woven City, Toyota is aiming to transform itself into a mobility company and will conduct many demonstrations with various partners. With Woven City, Toyota is taking on the challenge of pursuing well-being for all and expanding the very definition of "mobility" to make it more human-centered. The word "mobility" includes not only getting from point A to point B, but also "moving" people's hearts.
Under the slogan "Beyond Instant Foods," Nissin Foods is taking on the challenge of creating a new food culture that goes beyond the value of instant foods. As one of these efforts, Nissin Foods has been researching "Complete Nutrition Meals" that provide all the necessary nutrients with controlled calories, salt, sugar, and fat, while maintaining the appearance and taste of the food. Applying the technology they have developed for instant noodles and other products, Nissin Foods is making various efforts to realize food for the future by utilizing proprietary and cutting-edge food production technology.
Nissin Foods' goal of "Beyond Instant Foods" and Toyota Woven City's goal of "broadening the scope of mobility" are essentially the same, even if the industries involved are different. These aspirations of both companies are in line with each other, and have led to this basic agreement. The two companies will work together to realize well-being through food by offering Nissin Foods' "Complete Nutrition Meals" in Woven City, aiming for delicious and healthy products that are optimized for each individual’s needs.
“We strongly share Toyota's vision of ‘well-being for all’ and are very pleased to be a part of Woven City. This initiative is the first step toward realizing a ‘new diet’ that allows people to enjoy a ‘Complete Nutrition Meal’ optimized for each individual anytime, anywhere. We will continue to work on improving well-being through food by conducting medium to long-term demonstrations in Woven City based on the themes of ‘food and nutrition’ and ‘the correlation between food and the extension of healthy life expectancy.’ We will continue to take on further challenges to realize a world where people can enjoy whatever they want, whenever they want, and as much as they want, as never seen before, under the slogan "#Japan as a nation on the cutting edge of preventive medicine.”
Noritaka Ando, Executive Vice President & Representative Director, Chief Operating Officer of NISSIN FOODS HOLDINGS CO., LTD. and President & Representative Director of Nissin Food Products Co., Ltd.
“We are excited to partner with Nissin Foods, Japan’s leading food production company which is on an ongoing mission to create a new food culture beginning with the development of the world's first instant noodles. Through Woven City, Toyota strives to achieve well-being for all by conducting trials that will expand the meaning and value of ‘mobility’ and create healthy and satisfying eating experiences that ‘move’ people's hearts. While health requirements and eating preferences differ across individuals, within the living laboratory of Woven City, we will learn more about how custom diets inspire healthier lifestyles and greater happiness.
The problem of food waste and lack of access to affordable, healthy food is a global human rights issue. Toyota and Woven Planet believe that Toyota Production System principles that Toyota developed and implemented in Just-In-Time delivery of parts and supplies for manufacturing operations, have the potential to improve food supply chain operations, optimize freshness, and reduce food waste, if applied to food production and delivery.”
James Kuffner, Board of Directors Member and Chief Digital Officer of Toyota Motor Corporation and CEO of Woven Planet, Inc.
About Nissin Foods:
Nissin Food Products Co., Ltd. (Nissin Foods) history begins in 1958, from the invention of the world's first instant noodles, Chicken Ramen. Since then, Nissin Foods has continued to create new food cultures through the development of products such as the first cup-type instant noodles, Cup Noodles, and the world's first space food ramen, Space Ram. The instant noodles market has since been growing globally, now reaching an annual consumption of 100 billion servings. As a pioneer in creating new food cultures, Nissin Foods will continue to lead the global food scene through creativity and technology, under the slogan: "Beyond Instant Foods".
For more information, please visit https://www.nissin.com/en_jp/
About Toyota Motor Corporation
Toyota Motor Corporation (Toyota) (NYSE: TM) is the global mobility company that introduced the Prius hybrid-electric car in 1997 and the first mass-produced fuel cell sedan, Mirai, in 2014. Headquartered in Toyota City, Japan, Toyota has been making cars since 1937. Today, Toyota proudly employs 370,000 employees in communities around the world. Together, they build around 10 million vehicles per year in 28 countries and regions, from mainstream cars and premium vehicles to mini-vehicles and commercial trucks, and sell them in more than 170 countries and regions under the brands Toyota, Lexus, Daihatsu and Hino.
For more information, please visit https://global.toyota/en
About Woven Planet
Woven Planet is building the safest mobility in the world. A subsidiary of Toyota, Woven Planet innovates and invests in new technologies, software, and business models that transform how we live, work and move. With a focus on automated driving, smart cities, robotics and more, Woven Planet builds on Toyota's legacy of trust to deliver secure, connected, reliable, and sustainable mobility solutions for all.
Learn more at https://www.woven-planet.global/en
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220425005380/en/
Contact information
Public Relations, Woven Planet Holdings, Inc.
pr@woven-planet.global
https://www.woven-planet.global/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Ilsong Educational Foundation Chairman Dai-Won Yoon Wins Linnaeus Medal as the First in Asia2.6.2023 11:00:00 CEST | Press release
On May 30, Chairman Dai-Won Yoon of Ilsong Educational Foundation received the Linnaeus Medal from Uppsala University at Hallym University. This makes him the first person from Asia to receive the award. Ilsong Educational Foundation operates Hallym University and Hallym University Medical Center. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230531005495/en/ Chairman Dai-Won Yoon (left) of Ilsong Educational Foundation received Linnaeus Medal as the 1st in Asia (Photo: Hallym University) Chairman Yoon is the honoree of 2020. The award ceremony, which had been postponed due to COVID-19, was held this year with a delegation led by Vice Chancellor Anders Hagfeldt of Uppsala University visiting Korea. The Linnaeus Medal to commemorate Carl Linnaeus, a Swedish botanist, is awarded annually by Uppsala University to a person who has made a significant contribution to the field of science. Chairman Yoon was honored for his work in
10 th Annual World Patient Safety, Science & Technology Summit Begins2.6.2023 08:15:00 CEST | Press release
Day one of the 10th Annual World Patient Safety, Science & Technology Summit presented by the Patient Safety Movement Foundation (PSMF) saw global leaders across the world of patient safety call for an increased urgency in addressing the issue of preventable harm within healthcare. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230601006140/en/ Joe Kiani, founder of the Patient Safety Movement Foundation, speaks at the 10th Annual World Patient Safety, Science & Technology Summit in Newport Beach, California. (Photo: Business Wire) Celebrating the PSMF’s 10th anniversary, Dr. Michael Ramsay, chief executive officer of the PSMF, reflected on the role that the increasing availability of hospital data on medical errors could play in reducing harm. “I’m very optimistic that we’re really going to see a difference in healthcare,” he said. “Technology is changing. We’re now getting real data. We know what the outcomes are in hospit
Autel Energy Holds Partner Summit in Amsterdam, Mapping Out Europe Strategy2.6.2023 08:00:00 CEST | Press release
Autel Energy, a leading provider of EV charging products and services, successfully hosted the Autel Partner Summit at Muziekgebouw in Amsterdam from May 31 to June 1, 2023. The event not only showcased Autel’s visionary Europe strategy for the next two years but also provided partners opportunities to gain insights into the company's vision, and learn about Autel’s new products. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230525005428/en/ A quick afternoon bite with the Autel partners. (Photo: Business Wire) The Partner Summit helped Autel Energy to strengthen its partnerships in Europe and highlighted its collaborations with key clients. Notable partners in attendance included Maxicharger AC clients such as Sevadis and Deta, as well as Maxicharger DC clients such as Floading, Gasgas, and eWays. The company also partnered with CPO clients like Fastway and Powerdo, as well as energy companies like Enefit. The Summit was d
PL BioScience and Macopharma enter into a Patent License and Assignment Agreement regarding Human Platelet Lysate (HPL) cell culture supplements.2.6.2023 07:22:00 CEST | Press release
PL BioScience GmbH, a German life science company specializing in the production and development of Human Platelet Lysate (HPL) for cell expansion, today announced a Patent License and Assignment Agreement with the French company Macopharma S.A.S. As a result of the Agreement, PL BioScience will hereby accept a worldwide license under the patents filed by Macopharma, with a right to sublicense (through multiple tiers), for the duration of the license period. In addition to the Patent License and Assignment Agreement, Macopharma will introduce PL BioScience to their current HPL customers, and thanks to a comprehensive comparative evaluation showing equivalence of HPL products from PL BioScience, Macopharma HPL customers will have the opportunity to transfer their future orders to PL BioScience with minimal disruption. About PL BioScience: Located in Aachen in Germany, PL BioScience GmbH is a life science company specializing in the production and development of Human Platelet Lysate (HP
AOP Health: Completed Study Strengthens Clinical Development Program for ropeginterferon alpha 2b (Besremi®) in polycythaemia vera2.6.2023 04:00:00 CEST | Press release
With the publication of the final results from the LOW-PV study in the New England Journal of Medicine Evidence conducted by Fondazione per la Ricerca dell'Ospedale di Bergamo (FROM) under the leadership of Professor Tiziano Barbui, AOP Health announces an important advancement reinforcing its clinical development program for ropeginterferon alpha-2b (BESREMi®) in polycythaemia vera (PV), a rare blood cancer. The academic LOW-PV study supported and funded by AOP Health and public organizations in Italy complements a series of trials performed by AOP Health over more than 10 years to achieve marketing authorization in Europe and the Middle East. With these clinical studies, including PEGINVERA,PROUD-PV, and CONTINUATION-PV, AOP Health opened a new area of treatment options for patients suffering from PV. A further study (PEN-PV) was performed to develop a pen for self-injection allowing ease of self-administration, exact dosing and minimal waste of the medical product. AOP Health’s comp
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom